Literature DB >> 29295151

Constructing a Gene-Drug-Adverse Reactions Network and Inferring Potential Gene-Adverse Reactions Associations Using a Text Mining Approach.

MingShuang Sui1, Lei Cui1.   

Abstract

Our objective was to identify and extract gene-drug and drug-adverse drug reaction (ADR) relationships from different biomedical literature collections, and to predict the possible association between gene and ADR. The drug, ADR and gene entities were recognized by a CRF model with multiple features. Logistic regression models were constructed for each drug-ADR and drug-gene pair based on its frequency, Mesh Rule association and similarity with known association etc. Using predicted score to generate drug-ADR matrix and drug-gene matrix, and then calculating for gene-ADR matrix. Network and clustering analysis were applied to verify and interpret the relationship between them. A total of 78014 potential gene-ADR associations were predicted. Part of the predicted results can be explained by the network-clustering-pathway analysis, and verified in the literature. The gene-drug-ADR network constructed in this study can provide a reference for the possible association between the gene and ADR.

Entities:  

Keywords:  Algorithms; Data Mining; Drug-Related Side Effects and Adverse Reactions

Mesh:

Year:  2017        PMID: 29295151

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  2 in total

1.  A Text Mining Protocol for Extracting Drug-Drug Interaction and Adverse Drug Reactions Specific to Patient Population, Pharmacokinetics, Pharmacodynamics, and Disease.

Authors:  Mohamed Saleem Abdul Shukkoor; Mohamad Taufik Hidayat Baharuldin; Kalpana Raja
Journal:  Methods Mol Biol       Date:  2022

2.  A Text Mining Protocol for Predicting Drug-Drug Interaction and Adverse Drug Reactions from PubMed Articles.

Authors:  Mohamed Saleem Abdul Shukkoor; Kalpana Raja; Mohamad Taufik Hidayat Baharuldin
Journal:  Methods Mol Biol       Date:  2022
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.